The submission deadline has passed. The page is kept for reference. View active tenders →
Tender Details
Description / Scope of Work
UNICEF Pakistan is inviting Expressions of Interest from eligible pharmaceutical manufacturers for the supply of pharmaceutical products. This procurement notice is issued by UNICEF Pakistan to identify and engage qualified suppliers capable of meeting the organization's pharmaceutical supply requirements across Pakistan, particularly in Sindh province. The scope encompasses various pharmaceutical products needed to support UNICEF's health and humanitarian programmes. Interested manufacturers must meet UNICEF's stringent eligibility criteria and quality standards for pharmaceutical manufacturing and supply. Eligible manufacturers are required to possess valid pharmaceutical manufacturing licenses and comply with Good Manufacturing Practice standards. Bidders must demonstrate their capacity to supply quality pharmaceutical products and maintain regulatory compliance with relevant Pakistani pharmaceutical authorities. Complete details regarding eligibility requirements, technical specifications, and submission instructions are available through the UNGM portal link provided in this notice. Manufacturers interested in participating should carefully review all requirements and documentation guidelines before submitting their expressions of interest. The procurement process is transparent and conducted in accordance with UNICEF's procurement policies and United Nations regulations to ensure fair competition among qualified suppliers.
For Bidders: Our Analysis PAKISTANTENDER INSIGHT
Independent analysis by PakistanTender — not part of the official notice. Always confirm details against the original tender document.
UNICEF Pakistan seeks qualified pharmaceutical manufacturers for product supply supporting health/humanitarian programmes, primarily in Sindh.
This is a framework engagement via Expression of Interest—not a fixed-quantity tender—suggesting potential for recurring orders once pre-qualified. Scale appears medium to large given UNICEF's operational scope. Key challenge: stringent GMP compliance and regulatory alignment with Pakistani authorities required upfront; manufacturers must be investment-ready with licensed facilities. Timeline to EOI closure is 20+ months, indicating deliberate pre-qualification phase rather than urgent procurement.
Who can bid: Manufacturers must hold valid Pakistani pharmaceutical manufacturing licenses and demonstrate GMP compliance. Typically requires NTN registration, SECP incorporation, and PEC registration if applicable. UNICEF will apply additional quality/capacity vetting per UN standards. No specific restrictions stated, but international quality benchmarks implied. Regulatory standing with DRAP (drug authority) essential.